Syros Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
TEN CAPITAL WEALTH ADVISORS, LLC | 05/04/2023 | 219 | $585 | 0.00% | 0.00% |
Syros Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 15 institutional investors and hedge funds held shares of Syros Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Ten Capital Wealth Advisors, LLC: 0
ACT CAPITAL MANAGEMENT, LLC: 0
PARAMETRIC PORTFOLIO ASSOCIATES LLC: 11,874
Amalgamated Financial Corp.: 8,113
QS Investors, LLC: 64,000
LADENBURG THALMANN FINANCIAL SERVICES INC.: 902
0.00% of Syros Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 5.14 M shares in the last 24 months. This purchase volume represents approximately $1.34 M in transactions.